Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis.
Wada T, Yamakawa K, Kabata D, Abe T, Ogura H, Shiraishi A, Saitoh D, Kushimoto S, Fujishima S, Mayumi T, Hifumi T, Shiino Y, Nakada TA, Tarui T, Otomo Y, Okamoto K, Umemura Y, Kotani J, Sakamoto Y, Sasaki J, Shiraishi SI, Takuma K, Tsuruta R, Hagiwara A, Masuno T, Takeyama N, Yamashita N, Ikeda H, Ueyama M, Fujimi S, Gando S.
Wada T, et al. Among authors: fujimi s.
Sci Rep. 2022 Jun 3;12(1):9304. doi: 10.1038/s41598-022-13346-3.
Sci Rep. 2022.
PMID: 35660774
Free PMC article.